This finding also highlights the possible usefulness of these variants in predicting lung cancer dissemination after radical therapy, especially since the OPN-CD44 axis is known to play a role in the progression of several solid tumors [21,22]. This evidence concerns the gene SPP1 and lung carcinoma.